Literature DB >> 29601101

Regulation of immune cell signaling by activated protein C.

Laura D Healy1,2, Rachel A Rigg3, John H Griffin1, Owen J T McCarty2,3,4.   

Abstract

Innate immune cells are an essential part of the host defense response, promoting inflammation through release of proinflammatory cytokines or formation of neutrophil extracellular traps. While these processes are important for defense against infectious agents or injury, aberrant activation potentiates pathologic inflammatory disease. Thus, understanding regulatory mechanisms that limit neutrophil extracellular traps formation and cytokine release is of therapeutic interest for targeting pathologic diseases. Activated protein C is an endogenous serine protease with anticoagulant activity as well as anti-inflammatory and cytoprotective functions, the latter of which are mediated through binding cell surface receptors and inducing intracellular signaling. In this review, we discuss certain leukocyte functions, namely neutrophil extracellular traps formation and cytokine release, and the inhibition of these processes by activated protein C. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  APC; EPCR; Mac-1; PAR1; PAR3; activated protein C; neutrophils; sepsis

Year:  2018        PMID: 29601101      PMCID: PMC6165708          DOI: 10.1002/JLB.3MIR0817-338R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  95 in total

1.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C.

Authors:  Andrew J Gale; Alexander Tsavaler; John H Griffin
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

Review 3.  Neutrophils, from marrow to microbes.

Authors:  Niels Borregaard
Journal:  Immunity       Date:  2010-11-24       Impact factor: 31.745

Review 4.  Beneficial suicide: why neutrophils die to make NETs.

Authors:  Volker Brinkmann; Arturo Zychlinsky
Journal:  Nat Rev Microbiol       Date:  2007-08       Impact factor: 60.633

Review 5.  Getting to the site of inflammation: the leukocyte adhesion cascade updated.

Authors:  Klaus Ley; Carlo Laudanna; Myron I Cybulsky; Sussan Nourshargh
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

Review 6.  Mechanisms and functions of inflammasomes.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

7.  The effect of plasma-derived activated protein C on leukocyte cell-death and vascular endothelial damage.

Authors:  Toshiaki Iba; Kunihiko Nagakari
Journal:  Thromb Res       Date:  2015-03-14       Impact factor: 3.944

8.  Activated protein C enhances human keratinocyte barrier integrity via sequential activation of epidermal growth factor receptor and Tie2.

Authors:  Meilang Xue; Shu-Oi Chow; Suat Dervish; Yee-Ka Agnes Chan; Sohel M Julovi; Christopher J Jackson
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

9.  Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers.

Authors:  Patrick Lyden; Howard Levy; Sara Weymer; Kent Pryor; William Kramer; John H Griffin; Thomas P Davis; Berislav Zlokovic
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 10.  Resolution of inflammation: state of the art, definitions and terms.

Authors:  Charles N Serhan; Sue D Brain; Christopher D Buckley; Derek W Gilroy; Christopher Haslett; Luke A J O'Neill; Mauro Perretti; Adriano G Rossi; John L Wallace
Journal:  FASEB J       Date:  2007-02       Impact factor: 5.191

View more
  6 in total

Review 1.  Activated protein C in neuroprotection and malaria.

Authors:  Laurent O Mosnier
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

Review 2.  Thrombin generation and activity in multiple sclerosis.

Authors:  Kelley R Jordan; Ivan Parra-Izquierdo; András Gruber; Joseph J Shatzel; Peter Pham; Larry S Sherman; Owen J T McCarty; Norah G Verbout
Journal:  Metab Brain Dis       Date:  2021-01-07       Impact factor: 3.584

3.  Sex-dependent effects of genetic upregulation of activated protein C on delayed effects of acute radiation exposure in the mouse heart, small intestine, and skin.

Authors:  Vijayalakshmi Sridharan; Kristin A Johnson; Reid D Landes; Maohua Cao; Preeti Singh; Gail Wagoner; Abdallah Hayar; Emily D Sprick; Kayla A Eveld; Anusha Bhattacharyya; Kimberly J Krager; Nukhet Aykin-Burns; Hartmut Weiler; Jose A Fernández; John H Griffin; Marjan Boerma
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

4.  Pediatric Intensive Care: Immunomodulation With Activated Protein C ex vivo.

Authors:  Hassan O Eliwan; William R G Watson; Irene Regan; Brian Philbin; Fiona M O'Hare; Tammy Strickland; Amanda O'Neill; Michelle O'Rourke; Alfonso Blanco; Martina Healy; Beatrice Nolan; Owen Smith; Eleanor J Molloy
Journal:  Front Pediatr       Date:  2019-09-27       Impact factor: 3.418

5.  Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction.

Authors:  Tami Livnat; Yehonatan Weinberger; José A Fernández; Alaa Bashir; Gil Ben-David; Dahlia Palevski; Sarina Levy-Mendelovich; Gili Kenet; Ivan Budnik; Yael Nisgav; John H Griffin; Dov Weinberger
Journal:  Biomolecules       Date:  2021-02-26

6.  COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation.

Authors:  John H Griffin; Patrick Lyden
Journal:  Res Pract Thromb Haemost       Date:  2020-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.